Rubella seroprevalence in pregnant women in North Thames: Estimates based on newborn screening samples

Journal of Medical Screening

Volumn 16, Issue 1, 2009, Pages 1-6

  Hardelid, P ^a,b   Cortina Borja, M ^b   Williams, D ^b   Tookey, P A ^b   Peckham, C S ^b   Cubitt, W D ^c   Dezateux, C ^b  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c Great Ormond Street Hospital NHS Trust ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; MATERNAL ANTIBODY; RUBELLA ANTIBODY; RUBELLA VACCINE;

ADULT; AFRICA SOUTH OF THE SAHARA; ARTICLE; BIRTHPLACE; BLOOD SAMPLING; CONFIDENCE INTERVAL; DISEASE PREDISPOSITION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNIZATION; MAJOR CLINICAL STUDY; MATERNAL AGE; MEDICAL EXAMINATION; MIGRATION; NEWBORN; NEWBORN SCREENING; PREGNANT WOMAN; PREVALENCE; PREVENTIVE HEALTH SERVICE; PUERPERIUM; RISK ASSESSMENT; RUBELLA; SEROPREVALENCE; SOUTH ASIA; UNITED KINGDOM; VACCINATION; EPIDEMIOLOGY; METHODOLOGY; PREGNANCY;

ADULT; FEMALE; GREAT BRITAIN; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; PREGNANCY; RUBELLA; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 67049169339     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1258/jms.2009.008080     Document Type: Article

References (45)

1. Peckham C. Congenital rubella in the United Kingdom before 1970: the prevaccine era. Rev Infect Dis 1985;7 (Suppl 1):S11-6
2. Health Protection Agency. Rubella notifications (confirmed cases) England andWales, 1995-2007 by quarter. Available from: http://www.hpa.org.uk/ infections/topics-az/rubella/data-rub-not.htm. Last accessed 11 January 2008
3. Tookey P. Congenital rubella BPSU 20th Annual Report 2006-2007. Available from: http://bpsu.inopsu.com/publications/annual-reports/ BPSU%20Annual%20report%202006-7.pdf. Last accessed 28 June 2008
4. Gabutti G, Rota MC, Salmaso S, Bruzzone BM, Bella A, Crovari P. Epidemiology of measles, mumps and rubella in Italy. Epidemiol Infect 2002;129:543-550 (Pubitemid 36157678)
5. Panagiotopoulos T, Antoniadou I, Valassi-Adam E. Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review. BMJ 1999;319:1462-1467
6. Office for National Statistics. International Migration: Migrants entering or leaving the United Kingdom and England and Wales 2006. Available from: http://www.statistics.gov.uk/downloads/theme-population/MN33.pdf. Last accessed 28 August 2006
7. Miller E, Waight P, Rousseau SA, et al. Congenital rubella in the Asian community in Britain. BMJ 1990;301:1391
8. Miller E, Nicoll A, Rousseau SA, et al. Congenital rubella in babies of south Asian women in England and Wales: an excess and its causes. Br Med J (Clin Res.Ed) 1987;294:737-739 (Pubitemid 17044804)
9. Tookey PA, Cortina-Borja M, Peckham CS. Rubella susceptibility among pregnant women in North London, 1996-1999. J Public Health Med 2002;24:211-216
10. NHS Information Centre. NHS Immunisation Statistics, England 2006-2007. Available from: http://www.ic.nhs.uk/webfiles/publications/immstats2005to2006/ Final%202006-07%20Immunisation%20Bulletin%20%28with%20copyright%29.pdf. Last accessed 27 June 2007
11. Anderson RM, Grenfell BT. Quantitative investigations of different vaccination policies for the control of congenital rubella syndrome (CRS) in the United Kingdom. J Hyg (Lond) 1986;96:305-333 (Pubitemid 16117625)
12. Nokes DJ, Anderson RM. Measles, mumps, and rubella vaccine: what coverage to block transmission? Lancet 1988;2:1374
13. Atkinson P, Cullinan C, Jones J, Fraser G, Maguire H. Large outbreak of measles in London: reversal of health inequalities. Arch Dis Child 2005;90:424-425 (Pubitemid 40488687)
14. Ashmore J, Addiman S, Cordery R, Maguire H. Measles in North East and North Central London, England: a situation report. Euro Surveill 2007;12:E070920
15. Health Protection Agency. Increase in measles in 2006, in England and Wales. CDR Weekly 2006;16:3
16. World Health Organisation. Eliminating measles and rubella and preventing congenital rubella infection: WHO European Region strategic plan 2005-2010. Available from: http://www.euro.who.int/Document/E87772.pdf. Last accessed 27 June 2008
17. Department of Health. Screening for infectious diseases in pregnancy. Available from: http://www.dh.gov.uk/assetRoot/04/09/20/49/04092049.pdf. Last accessed 28 June 2008
18. National Institute of Clinical Excellence. Antenatal care: routine care for the healthy pregnant woman. Available from: http://www.rcog.org.uk/ resources/Public/pdf/Antenatal-Care.pdf. Last accessed 28 June 2008
19. Anderson SR, Righarts A, Maguire H. Surveillance of antenatal infections- HIV, hepatitis B, syphilis and rubella susceptibility in London. Commun Dis Public Health 2004;7:251-257
20. Ades AE. Evaluating screening tests and screening programmes. Arch Dis Child 1990;65:792-795 (Pubitemid 20220446)
21. Leineweber B, Grote V, Schaad UB, Heininger U. Transplacentally acquired immunoglobulin G antibodies against measles, mumps, rubella and varicella-zoster virus in preterm and full term newborns. Pediatr Infect Dis J 2004;23:361-363 (Pubitemid 38508894)
22. Goncalves G, Nascimento MSJ, Reu C, Cutts FT. Levels of rubella antibody among vaccinated and unvaccinated Portuguese mothers and their newborns. Vaccine 2006;24:7142-7147 (Pubitemid 46107202)
23. UK Newborn Screening Programme Centre. Newborn blood spot screening in the UK: policies and standards. Available from: http://www.ich.ucl.ac.uk/ newborn/download/policies-standards.pdf. Last accessed 12 March 2007
24. Ades AE, Walker J, Jones R, Smith I. Coverage of neonatal screening: failure of coverage or failure of information system. Arch Dis Child 2001;84:476-479 (Pubitemid 33027585)
25. Cortina-Borja M, Cliffe S, Tookey P, Williams D, Cubitt WD, Peckham C. HIV prevalence in pregnant women in an ethnically diverse population in the UK: 1998-2002. Aids 2004;18:535-540
26. Hardelid P, Williams D, Dezateux C, et al. Agreement of rubella IgG antibody measured in serum and dried blood spots using two commercial enzyme-linked immunosorbent assays. J Med Virol 2008;80:360-364
27. Gay NJ, Vyse AJ, Enquselassie F, Nigatu W, Nokes DJ. Improving sensitivity of oral fluid testing in IgG prevalence studies: application of mixture models to a rubella antibody survey. Epidemiol Infect 2003;130:285-291 (Pubitemid 36511968)
28. Vyse AJ, Gay NJ, Hesketh LM, Pebody R, Morgan-Capner P, Miller E. Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century. Epidemiol.Infect. 2006;134:1303-1312 (Pubitemid 44614954)
29. Talukder YS, Kafatos G, Pinot de MA, et al. The seroepidemiology of varicella zoster virus among pregnant Bangladeshi and white British women in the London Borough of Tower Hamlets, UK. Epidemiol Infect 2007;135:1344-1353 (Pubitemid 351148096)
30. Ades AE, Walker J, Botting B, Parker S, Cubitt D, Jones R. Effect of the worldwide epidemic on HIV prevalence in the United Kingdom: record linkage in anonymous neonatal seroprevalence surveys. Aids 1999;13:2437-2443
31. van Buuren S, Oudshoorn S. Flexible multivariate imputation by MICE. TNO report PG/VGZ/99.054 Available from: http://web.inter.nl.net/users/S.van.Buuren/ mi/docs/rapport99054.pdf. Last accessed 28 June 2008
32. StataCorp. Intercooled Stata 9.0
33. Carlin JB, Li N, Greenwood P, Carolyn Coffey. Tools for analyzing multiple imputed datasets. The Stata Journal 2003;3:226-244
34. Carlin JB, Galati JC, Royston P. A new framework for managing and analysing multiply imputed data in STATA. The Stata Journal 2008;8:49-67
35. World Health Organisation. WHO vaccine-preventable diseases monitoring system: 2006 global summary. Available from: http://www.who.int/vaccines- documents/GlobalSummary/GlobalSummary.pdf. Last accessed 27 June 2008
36. Rafila A, Marin M, Pistol A, Nicolaiciuc D, Lupulescu E, Uzicanin A, et al. A large rubella outbreak, Romania-2003. Euro Surveill 2004;9:7-9
37. Panagiotopoulos T, Georgakopoulou T. Epidemiology of rubella and congenital rubella syndrome in Greece, 1994-2003. Euro Surveill 2004;9:17-19
38. Ciofi degli AM, Filia A, Revello MG, Buffolano W, Salmaso S. Rubella control in Italy. Euro Surveill 2004;9:19-21
39. Giraudon I, Trail P, Arnold J, Maguire H. Antenatal infection screening surveillance in London 2000 to 2004. Health Protection Agency
40. Linder N, Sirota L, Aboudy Y, et al. Placental transfer of maternal rubella antibodies to full-term and preterm infants. Infection 1999;27:203-207 (Pubitemid 29257746)
41. Griffiths PD, Berney SI, Argent S, Heath RB. Antibody against viruses in maternal and cord sera: specific antibody is concentrated on the fetal side of the circulation. J Hyg (Lond) 1982;89:303-310 (Pubitemid 13250594)
42. McLachlan G, Peel D. Finite mixture models. New York: John Wiley and Sons, 2000
43. Leisch F. FlexMix: A general framework for finite mixture models and latent class reduction in R. J Stat Soft 2004;11:1-18 (Pubitemid 40068149)
44. R Development Core Team. R: A language and environment for statistical computing. Available from: http://www.r-project.org. Last accessed 28 June 2008
45. Kuha J. AIC and BIC - Comparisons of assumptions and performance. Sociological Methods & Research 2004;33:188-229 (Pubitemid 39519122)